Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pulmonx Corp Director's Dealing 2020

Oct 2, 2020

34428_dirs_2020-10-02_1d81b137-8ab7-44cd-a6d7-9e29302f4f25.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2020-09-30

Reporting Person: FERRARI RICHARD M (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-09-30 Employee Stock Option (right to buy) $19.0 A 25000 Acquired 2030-09-29 Common Stock (25000.0) Direct

Footnotes

F1: The shares subject to the option vest in 36 equal consecutive monthly installments commencing on September 30, 2020, subject to the Reporting Person's continuous service through each such vesting date.